Advertisement

Application of PET–CT in Genitourinary Malignancies

  • P. K. Pradhan
  • Raveena Mubalsha
Chapter

Abstract

18F-2-deoxy-d-glucose (FDG) has been the primary tracer for positron emission tomography (PET) in urologic malignancy. The primary clinical application of PET–CT in urology relates to the management of the urologic malignancies, including renal cancer, bladder cancer, prostate cancer, and testicular cancer.

Keywords

Positron Emission Tomography Cervical Cancer Bladder Cancer Standardize Uptake Value Renal Mass 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

For Further Reading

  1. 1.
    Aide N, Cappele O, Bottet P, Bensadoun H, Regeasse A, Comoz F, et al. Efficiency of [(18)F] FDG PET in characterizing renal cancer and detecting distant metastases: a comparison with CT. Eur J Nucl Med Mol Imaging. 2003;30:1236–45.PubMedCrossRefGoogle Scholar
  2. 2.
    De Hullu JA, Pruim J, Que TH, et al. Noninvasive detection of inguinofemoral lymph node metastases in squamous cell cancer of the vulva by L-[1e11C] tyrosine positron emission tomography. Int J Gynecol Cancer. 1999;9(2):141e6.Google Scholar
  3. 3.
    De Jong IJ, Pruim J, Elsinga PH, Jongen MM, Mensink HJ, Vaalburg W. Visualisation of bladder cancer using C-11-choline PET: first clinical experience. Eur J Nucl Med Mol Imaging. 2002;29:1283–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Grigsby PW, Siegel BA, Dehdashti F, Rader J, Zoberi I. Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. J Clin Oncol. 2004;22:2167–71.PubMedCrossRefGoogle Scholar
  5. 5.
    Hain SF, O’Doherty MJ, Timothy AR, et al. Fluoro deoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse. Br J Cancer. 2000;83:863–9.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Ho KC, Lai CH, Wu TI, et al. 18F-fluorodeoxyglucose positron emission tomography in uterine carcinosarcoma. Eur J Nucl Med Mol Imaging. 2008;35(3):484–92.PubMedCrossRefGoogle Scholar
  7. 7.
    Kitajima K, Murakami K, Yamasaki E, et al. Performance of integrated FDG-PET/contrast enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT. Eur J Nucl Med Mol Imaging. 2009;36(3):362–72.PubMedCrossRefGoogle Scholar
  8. 8.
    Lamoreaux WT, Grigsby PW, Dehdashti F, et al. FDG-PET evaluation of vaginal carcinoma. Int J Radiat Oncol Biol Phys. 2005;62(3):733–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Lassen U, Daugaard G, Eigtved A, et al. Whole body FDG-PET in patients with stage I non-seminomatous germ cell tumours. Eur J Nucl Med Mol Imaging. 2003;30:396–402.PubMedCrossRefGoogle Scholar
  10. 10.
    Price DT, Coleman RE, Liano RP, Robertson CN, Polascik TJ, DeGrado TR. Comparison of [18F] fluorocholine and (18F) fluoro deoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer. J Urol. 2002;168:273–80.PubMedCrossRefGoogle Scholar
  11. 11.
    Risum S, Hogdall C, Loft A, et al. The diagnostic value of PET-CT for primary ovarian cancer- a prospective study. Gynecol Oncol. 2007;105(1):145–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Safaei A, Figlin R, Hoh CK, Silverman DH, Seltzer M, Phelps ME, Czernin J. The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer. Clin Nephrol. 2002;57:56–62.PubMedCrossRefGoogle Scholar
  13. 13.
    Singh AK, Grigsby PW, Dehdashti F, Herzog TJ, Siegel BA. FDGPET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma. Int J Radiat Oncol Biol Phys. 2003;56(2):489–93.PubMedCrossRefGoogle Scholar
  14. 14.
    Toth G, Lengyel Z, Balkay L, Salah MA, Tron L, Toth C. Detection of prostate cancer with 11C-methionine positron emission tomography. J Urol. 2005;173:66–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer India 2015

Authors and Affiliations

  1. 1.Department of Nuclear Medicine and PETSanjay Gandhi Postgraduate Institute of Medical SciencesLucknowIndia

Personalised recommendations